UK Innovation & Science Seed Fund

Type

Venture Capital

Status

Active

Location

London, United Kingdom

Total investments

107

Average round size

2M

Portfolio companies

64

Rounds per year

4.86

Lead investments

20

Follow on index

0.40

Exits

5

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareManufacturingMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsElectronics

Summary

In 2002 was created UK Innovation & Science Seed Fund, which is appeared as VC. The main office of represented VC is situated in the Harwell. The fund was located in Europe if to be more exact in United Kingdom.

We also calculated 3 valuable employees in our database.

The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2018. Opposing the other organizations, this UK Innovation & Science Seed Fund works on 22 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2019.

The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight P2i, Crescendo Biologics, The Electrospinning Company. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Electronics, Pharmaceutical.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the UK Innovation & Science Seed Fund, startups are often financed by Newable Private Investing, Sofinnova Partners, Providence Investment Company Limited. The meaningful sponsors for the fund in investment in the same round are Oxford Technology Management, Midven, Development Bank of Wales. In the next rounds fund is usually obtained by Newable Private Investing, Midven, Oxford Technology Management.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesMilitaryCybersecurityClimate techDeep Tech
Stage focus
SeedSeries APre-SeedSeries B
Geo focus
United Kingdom
Check size
125K — 2M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
107
Lead investments
20
Exits
5
Rounds per year
4.86
Follow on index
0.40
Investments by industry
  • Biotechnology (61)
  • Health Care (33)
  • Medical (22)
  • Therapeutics (17)
  • Manufacturing (17)
  • Show 66 more
Investments by region
  • United Kingdom (105)
  • United States (1)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
3M
Group Appearance index
0.79
Avg. company exit year
7
Avg. multiplicator
1.84

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
NK:IO 25 Jul 2023 Biotechnology, Manufacturing, Life Science, Therapeutics Seed 1M
Vector Photonics 07 Jun 2024 Semiconductor Seed 2M Glasgow, Glasgow City, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.